Paper18242516
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.
Chesi M and 13 others. Cancer Cell, 2008. Cited by 312 papers, by iCite.
Cite this record
ConductScience Library. AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Papers, record 18242516. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18242516
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytidine Deaminase | Major topic |
| Germinal Center | Major topic |
| Multiple Myeloma | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Transgenes | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Cell Proliferation | |
| Codon, Terminator | |
| DNA Mutational Analysis | |
| Disease Models, Animal | |
| Disease Progression | |
| Drug Screening Assays, Antitumor | |
| Gene Expression Profiling | |
| Humans | |
| Immunization | |
| Mice | |
| Models, Biological | |
| Molecular Sequence Data | |
| Organ Specificity | |
| Paraproteinemias | |
| Plasma Cells | |
| Protein Engineering | |
| Somatic Hypermutation, Immunoglobulin | |
| AICDA (Activation-Induced Cytidine Deaminase) |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01-CA83724 | NCI NIH HHS | United States | R01CA083724 | PubMed and NIH | NIH RePORTER |
| P01-CA62242 | NCI NIH HHS | United States | P01CA062242 | PubMed and NIH | NIH RePORTER |
| R01 AG020686 | NIA NIH HHS | United States | R01AG020686 | PubMed and NIH | NIH RePORTER |
| P50-CA100707 | NCI NIH HHS | United States | P50CA100707 | PubMed and NIH | NIH RePORTER |
| R01 CA129009 | NCI NIH HHS | United States | R01CA129009 | PubMed and NIH | NIH RePORTER |
| R01-AG020686 | NIA NIH HHS | United States | R01AG020686 | PubMed and NIH | NIH RePORTER |
| R56 AG020686 | NIA NIH HHS | United States | R01AG020686 | PubMed and NIH | NIH RePORTER |
| P50 CA100707 | NCI NIH HHS | United States | P50CA100707 | PubMed and NIH | NIH RePORTER |
| R01-CA129009 | NCI NIH HHS | United States | R01CA129009 | PubMed and NIH | NIH RePORTER |
| R56AG020686 | NIH | NIH RePORTER |
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15771579 | Antigen-specific memory B cell development. | Annu Rev Immunol | 2005 | https://conductscience.org/library/papers/15771579 | PubMed |
| 2 | 15315756 | AID is required for c-myc/IgH chromosome translocations in vivo. | Cell | 2004 | https://conductscience.org/library/papers/15315756 | PubMed |
| 3 | 15339850 | Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. | Blood | 2005 | https://conductscience.org/library/papers/15339850 | PubMed |
| 4 | 12826635 | A phase 2 study of bortezomib in relapsed, refractory myeloma. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12826635 | PubMed |
| 5 | 13867794 | Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806). | Cancer Chemother Rep | 1962 | https://conductscience.org/library/papers/13867794 | PubMed |
| 6 | 14707116 | BCMA is essential for the survival of long-lived bone marrow plasma cells. | J Exp Med | 2004 | https://conductscience.org/library/papers/14707116 | PubMed |
| 7 | 16199517 | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199517 | PubMed |
| 8 | 15004135 | Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. | J Immunol | 2004 | https://conductscience.org/library/papers/15004135 | PubMed |
| 9 | 3122026 | 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/3122026 | PubMed |
| 10 | 16616478 | Stromal niches, plasma cell differentiation and survival. | Curr Opin Immunol | 2006 | https://conductscience.org/library/papers/16616478 | PubMed |
| 11 | 8011279 | Germinal centers. | Annu Rev Immunol | 1994 | https://conductscience.org/library/papers/8011279 | PubMed |
| 12 | 3141270 | The influence of genetic factors associated with the immunoglobulin heavy chain locus on the development of benign monoclonal gammapathy in ageing IgH-congenic mice. | Immunology | 1988 | https://conductscience.org/library/papers/3141270 | PubMed |
| 13 | 2997407 | Single agent vincristine by infusion in refractory multiple myeloma. | J Clin Oncol | 1985 | https://conductscience.org/library/papers/2997407 | PubMed |
| 14 | 15735016 | Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. | Cancer Res | 2005 | https://conductscience.org/library/papers/15735016 | PubMed |
| 15 | 6401867 | Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. | Science | 1983 | https://conductscience.org/library/papers/6401867 | PubMed |
| 16 | 16571879 | Prevalence of monoclonal gammopathy of undetermined significance. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16571879 | PubMed |
| 17 | 8502271 | Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8502271 | PubMed |
| 18 | 1956393 | Immunology. The centre of hypermutation. | Nature | 1991 | https://conductscience.org/library/papers/1956393 | PubMed |
| 19 | 10024885 | Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. | Mol Cell | 1999 | https://conductscience.org/library/papers/10024885 | PubMed |
| 20 | 14737125 | Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/14737125 | PubMed |
Cited by253
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 312 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42388417 | Multiple myeloma: A tale of deregulated transcription factors. | Hemasphere | 2026 | https://conductscience.org/library/papers/42388417 | PubMed |
| 41800118 | Uncoupled bone remodeling drives myeloma bone disease in Vk*MYC mouse model of multiple myeloma. | Bone Rep | 2026 | https://conductscience.org/library/papers/41800118 | PubMed |
| 41706224 | An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41706224 | PubMed |
| 41373634 | Beta-Arrestin 1 Deficiency Enhances Host Anti-Myeloma Immunity Through T Cell Activation and Checkpoint Modulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373634 | PubMed |
| 41359792 | Evolution of multiple myeloma from a genomic perspective. | Blood | 2026 | https://conductscience.org/library/papers/41359792 | PubMed |
| 41342739 | A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model. | Cancer Discov | 2026 | https://conductscience.org/library/papers/41342739 | PubMed |
| 41285849 | Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. | Nat Commun | 2025 | https://conductscience.org/library/papers/41285849 | PubMed |
| 41090157 | B-cell-specific Wwox deletion promotes plasmablastic tumor development and proinflammatory signatures in myeloma model. | Blood Neoplasia | 2025 | https://conductscience.org/library/papers/41090157 | PubMed |
| 41013744 | NPC1 as a novel therapeutic target for induction of pyroptosis in cancers. | Biomark Res | 2025 | https://conductscience.org/library/papers/41013744 | PubMed |
| 40972551 | Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary level. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/40972551 | PubMed |
| 40920573 | Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy. | Blood | 2025 | https://conductscience.org/library/papers/40920573 | PubMed |
| 40795066 | A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40795066 | PubMed |
| 40758944 | Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma. | Blood | 2025 | https://conductscience.org/library/papers/40758944 | PubMed |
| 40623045 | Immune alterations in myeloma evolution and outcomes: quo vadis? | Blood | 2025 | https://conductscience.org/library/papers/40623045 | PubMed |
| 40502919 | Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy. | Mol Ther Oncol | 2025 | https://conductscience.org/library/papers/40502919 | PubMed |
| 40114373 | Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40114373 | PubMed |
| 39755583 | Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/39755583 | PubMed |
| 39693340 | Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39693340 | PubMed |
| 39674742 | Immunocompetent mouse models of multiple myeloma. | Semin Hematol | 2025 | https://conductscience.org/library/papers/39674742 | PubMed |
| 39482742 | The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39482742 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDA | 978 | PubTator's text mining | https://conductscience.org/library/genes/978 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Data15
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession | Source |
|---|---|---|
| GENBANK | EU359464 | GENBANK |
| GENBANK | EU359465 | GENBANK |
| GENBANK | EU359466 | GENBANK |
| GENBANK | EU359467 | GENBANK |
| GENBANK | EU359468 | GENBANK |
| GENBANK | EU359470 | GENBANK |
| GENBANK | EU359471 | GENBANK |
| GENBANK | EU359472 | GENBANK |
| GENBANK | EU359473 | GENBANK |
| GENBANK | EU359474 | GENBANK |
| GENBANK | EU359475 | GENBANK |
| GENBANK | EU359476 | GENBANK |
| GENBANK | EU359477 | GENBANK |
| GENBANK | EU359478 | GENBANK |
| GENBANK | EU359479 | GENBANK |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18242516
GET https://conductscience.org/api/papers/v1/18242516/references?page=2